Gianluigi Forloni

Dr. Gianluigi Forloni

Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy

Research Focus & Metrics

Academic Career Length

48Years (1979-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1993 in Nature
Verified
Journal Article
Closed access
PDF file
GFGianluigi Forloni
Gianluigi Forloni
NANadia Angeretti
Nadia Angeretti
RCRoberto Chiesa
Roberto Chiesa
EMEnrico Monzani
Enrico Monzani
MSMario Salmona
Mario Salmona
FTFabrizio Tagliavini
Fabrizio Tagliavini

19 January 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CBClaudia Balducci
Claudia Balducci
MBMarten Beeg
Marten Beeg
MSMatteo Stravalaci
Matteo Stravalaci
ABAntonio Bastone
Antonio Bastone
ASAlessandra Sclip
Alessandra Sclip
GFGianluigi Forloni
Gianluigi Forloni
Inability to form new memories is an early clinical sign of Alzheimer’s disease (AD). There is ample evidence that the amyloid-β (Aβ) peptide plays a key role in the pathogenesis of this disorder. Soluble, bio-derived oligomers of Aβ are proposed as the key mediators of synaptic and cognitive dysfunction, but more tractable models of Aβ−mediated cognitive impairment are needed. Here we report that, in mice, acute intracerebroventricular injections of synthetic Aβ 1–42 oligomers impaired consolidation of the long-term recognition memory, whereas mature Aβ 1–42 fibrils and freshly dissolved peptide did not. The deficit induced by oligomers was reversible and was prevented by an anti-Aβ antibody. It has been suggested that the cellular prion protein (PrP C ) mediates the impairment of synaptic plasticity induced by Aβ. We confirmed that Aβ 1–42 oligomers interact with PrP C , with nanomolar affinity. However, PrP-expressing and PrP knock-out mice were equally susceptible to this impairment. These data suggest that Aβ 1–42 oligomers are responsible for cognitive impairment in AD and that PrP C is not required.

1 July 2014 in The Lancet Neurology
Verified
Journal Article
Closed access
RFRaffaele Ferrari
Raffaele Ferrari
DHDena G Hernandez
Dena G Hernandez
MNMichael A Nalls
Michael A Nalls
JRJonathan D Rohrer
Jonathan D Rohrer
ARAdaikalavan Ramasamy
Adaikalavan Ramasamy
PMParastoo Momeni
Parastoo Momeni

1 June 2000 in Neuroscience Letters
Verified
Journal Article
Closed access
RBRoberta Borghi
Roberta Borghi
RMRoberta Marchese
Roberta Marchese
ANAlessandro Negro
Alessandro Negro
Lucio MarinelliLucio Marinelli
Lucio Marinelli
GFGianluigi Forloni
Gianluigi Forloni
MTMassimo Tabaton
Massimo Tabaton

1 July 2012 in The Lancet Neurology
Verified
Journal Article
Closed access
GPGianfranco Puoti
Gianfranco Puoti
ABAlberto Bizzi
Alberto Bizzi
GFGianluigi Forloni
Gianluigi Forloni
JSJiri G Safar
Jiri G Safar
FTFabrizio Tagliavini
Fabrizio Tagliavini
PGPierluigi Gambetti
Pierluigi Gambetti

1 May 1993 in NeuroReport
Verified
Journal Article
Closed access
GFGianluigi Forloni
Gianluigi Forloni
RCRoberto Chiesa
Roberto Chiesa
SSSimona Smiroldo
Simona Smiroldo
LVLaura Verga
Laura Verga
MSMario Salmona
Mario Salmona
NANadia Angeretti
Nadia Angeretti
To investigate whether and how amyloid-β protein (Aβ) is involved in the neurodegenerative changes characteristic of Alzheimer's disease (AD), primary hippocampal neurones from foetal rat brain were exposed acutely and chronically to micromolar concentrations of a synthetic peptide homologous to residues 25–35 of Aβ (β 25–35). A single application of this peptide (25–100 μM) was ineffective but when the neuronal culture were exposed to β 25–35 (25–100 μM) repeatedly every two days for ten days, cell survival was dramatically reduced. The structural changes and the DNA fragmentation of cells chronically exposed to the peptide suggested that neuronal death occurred by apoptosis. Furthermore, β 25–35 showed the intrinsic ability to polymerize into amyloid-like fibrils in vitro. These results confirm the potential pathogenic role of Aβ in AD, and indicate that amyloid fibrils may induce neuronal death through a specific programmed process.